Evolent Health, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Evolent Health, Inc. (EVH) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$6.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-02-25
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-12-31 was -$4.66M, a 210.90% decline year-over-year.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-09-30 was $1.09M.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-06-30 was -$3.21M.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-03-31 was $280.00K.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2025 was -$6.50M.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2024 was -$4.91M.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2023 was -$17.98M, a 169.98% decline from fiscal 2022.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2022 was $25.70M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$3.57M derived: sum of 2 quarters · filed 2026-02-25 | -$6.78M derived: sum of 3 quarters · filed 2026-02-25 | -$6.50M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$2.12M derived: sum of 2 quarters · filed 2025-11-07 | -$1.84M 10-Q · filed 2025-11-07 | $2.36M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2025-06-30 | -$3.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$2.93M 10-Q · filed 2025-08-11 | $1.27M derived: sum of 3 quarters · filed 2026-02-25 | $1.07M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2025-03-31 | $280.00K 10-Q · filed 2025-05-09 | $4.48M derived: sum of 2 quarters · filed 2026-02-25 | $4.28M derived: sum of 3 quarters · filed 2026-02-25 | $4.28M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.00M derived: sum of 2 quarters · filed 2026-02-25 | $4.00M derived: sum of 3 quarters · filed 2026-02-25 | -$4.91M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$200.00K derived: sum of 2 quarters · filed 2025-11-07 | -$9.11M 10-Q · filed 2025-11-07 | -$15.04M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$8.91M 10-Q · filed 2025-08-11 | -$14.85M derived: sum of 3 quarters · filed 2025-08-11 | -$26.14M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | -$8.91M 10-Q · filed 2025-05-09 | -$14.85M derived: sum of 2 quarters · filed 2025-05-09 | -$26.14M derived: sum of 3 quarters · filed 2025-05-09 | -$22.59M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | -$5.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$17.24M derived: sum of 2 quarters · filed 2025-02-21 | -$13.68M derived: sum of 3 quarters · filed 2025-02-21 | -$17.98M 10-K · filed 2025-02-21 | ||||
| 2023-09-30 | -$11.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$7.75M derived: sum of 2 quarters · filed 2024-11-08 | -$12.05M 10-Q · filed 2024-11-08 | $5.65M derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$747.00K 10-Q · filed 2024-08-09 | $16.95M derived: sum of 3 quarters · filed 2024-08-09 | $29.65M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | -$4.30M 10-Q · filed 2024-05-10 | $13.40M derived: sum of 2 quarters · filed 2024-05-10 | $26.10M derived: sum of 3 quarters · filed 2024-05-10 | $25.30M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $17.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $30.40M derived: sum of 2 quarters · filed 2024-02-23 | $29.60M derived: sum of 3 quarters · filed 2024-02-23 | $25.70M 10-K · filed 2024-02-23 | ||||
| 2022-09-30 | $12.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $11.90M derived: sum of 2 quarters · filed 2023-11-02 | $8.00M 10-Q · filed 2023-11-02 | -$6.10M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | -$800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$4.70M 10-Q · filed 2023-08-03 | -$18.80M derived: sum of 3 quarters · filed 2023-08-03 | -$18.80M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | -$3.90M 10-Q · filed 2023-05-04 | -$18.00M derived: sum of 2 quarters · filed 2023-05-04 | -$18.00M derived: sum of 3 quarters · filed 2023-05-04 | -$18.00M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$14.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$14.10M derived: sum of 2 quarters · filed 2023-02-24 | -$14.10M derived: sum of 3 quarters · filed 2023-02-24 | -$14.10M 10-K · filed 2023-02-24 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | $2.11M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $0.00 10-Q · filed 2022-08-03 | $2.11M derived: sum of 3 quarters · filed 2022-08-03 | $4.72M derived: sum of 4 quarters · filed 2022-08-03 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $2.11M derived: sum of 2 quarters · filed 2022-05-05 | $4.72M derived: sum of 3 quarters · filed 2022-05-05 | $6.12M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $4.72M derived: sum of 2 quarters · filed 2022-02-24 | $6.12M derived: sum of 3 quarters · filed 2022-02-24 | -$255.00K 10-K · filed 2022-02-24 | $255.00K 10-K · filed 2021-02-26 | |||
| 2020-09-30 | $2.61M 10-Q · filed 2020-11-06 | $4.01M derived: sum of 2 quarters · filed 2021-08-05 | -$2.36M 10-Q · filed 2021-11-04 | -$6.08M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$4.97M 10-Q · filed 2021-08-05 | -$8.69M derived: sum of 3 quarters · filed 2021-08-05 | -$9.19M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$6.38M 10-Q · filed 2021-05-06 | $6.38M 10-Q · filed 2020-05-28 | -$10.09M derived: sum of 2 quarters · filed 2021-05-06 | -$10.59M derived: sum of 3 quarters · filed 2021-05-06 | -$10.69M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | -$3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$4.22M derived: sum of 2 quarters · filed 2021-02-26 | -$4.32M derived: sum of 3 quarters · filed 2021-02-26 | -$4.02M 10-K · filed 2021-02-26 | $4.02M 10-K · filed 2020-03-02 | |||
| 2019-09-30 | -$500.00K 10-Q · filed 2020-11-06 | $500.00K 10-Q · filed 2019-11-05 | -$600.00K derived: sum of 2 quarters · filed 2020-11-06 | -$300.00K 10-Q · filed 2020-11-06 | $300.00K 10-Q · filed 2019-11-05 | $2.00M derived: sum of 4 quarters · filed 2020-11-06 | ||
| 2019-06-30 | -$100.00K 10-Q · filed 2019-08-09 | $200.00K 10-Q · filed 2020-08-07 | -$200.00K 10-Q · filed 2019-08-09 | $2.50M derived: sum of 3 quarters · filed 2020-05-28 | $2.40M derived: sum of 4 quarters · filed 2020-05-28 | |||
| 2019-03-31 | -$100.00K 10-Q · filed 2020-05-28 | $2.60M derived: sum of 2 quarters · filed 2020-05-28 | $2.50M derived: sum of 3 quarters · filed 2020-05-28 | $3.10M derived: sum of 4 quarters · filed 2020-05-28 | ||||
| 2018-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $2.60M derived: sum of 2 quarters · filed 2020-03-02 | $3.20M derived: sum of 3 quarters · filed 2020-03-02 | $3.10M 10-K · filed 2020-03-02 | ||||
| 2018-09-30 | -$100.00K 10-Q · filed 2019-11-05 | $500.00K derived: sum of 2 quarters · filed 2019-11-05 | $400.00K 10-Q · filed 2019-11-05 | $300.00K derived: sum of 4 quarters · filed 2019-11-05 | ||||
| 2018-06-30 | $600.00K 10-Q · filed 2019-08-09 | $500.00K 10-Q · filed 2019-08-09 | $400.00K derived: sum of 3 quarters · filed 2019-08-09 | $300.00K derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | -$100.00K 10-Q · filed 2019-05-09 | -$200.00K derived: sum of 2 quarters · filed 2019-05-09 | -$300.00K derived: sum of 3 quarters · filed 2019-05-09 | -$500.00K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$200.00K derived: sum of 2 quarters · filed 2019-02-28 | -$400.00K derived: sum of 3 quarters · filed 2019-02-28 | -$400.00K 10-K · filed 2019-02-28 | ||||
| 2017-09-30 | -$100.00K 10-Q · filed 2018-11-08 | -$300.00K derived: sum of 2 quarters · filed 2018-11-08 | -$300.00K 10-Q · filed 2018-11-08 | $1.79M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | -$200.00K 10-Q · filed 2018-08-09 | -$200.00K 10-Q · filed 2018-08-09 | $1.89M derived: sum of 3 quarters · filed 2018-08-09 | $1.89M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 | $2.09M derived: sum of 2 quarters · filed 2018-05-10 | $2.09M derived: sum of 3 quarters · filed 2018-05-10 | $2.09M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $2.09M derived: sum of 2 quarters · filed 2018-03-01 | $2.09M derived: sum of 3 quarters · filed 2018-03-01 | $2.09M 10-K · filed 2018-03-01 | -$2.09M 10-K · filed 2017-03-03 | |||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | |||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-07 | $0.00 10-Q · filed 2017-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |